The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
The medical community today faces a deceptively simple question: How quickly should we act when a child’s life is on the line? I’m a pediatric oncologist, so my answer won’t surprise you — I think we ...
HealthDay News — The FDA has approved a pediatric dose of the cancer drug everolimus (Afinitor Disperz, Novartis), to treat rare brain tumors in children aged 1 year and older. Prior to approval of ...
SELLAS Life Sciences Group, Inc. announced that it has dosed its first pediatric patient in a Phase 2 trial for SLS009 (tambiciclib), a selective CDK9 inhibitor targeting relapsed/refractory acute ...
On September 12, the Centers for Disease Control and Prevention recommended the next round of COVID shots for everyone 6 months and older. The CDC indicated that the shots would be available within ...
"The allogeneic stem cell transplant population, especially within the first year posttransplant, is one of the most immune-suppressed populations, therefore placing them at high risk for infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results